Federal award
CMC PHARMACEUTICALS, INC.
W911QY20C0003
ContractSBIR/STTR SR2
Obligated and Ceiling
- Obligated (net)
- $1,466,682.62
- Ceiling (potential value, not spending)
- $1,466,682.62
- Current value
- $1,466,682.62
- Gross positive obligations
- $1,466,682.62
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CMC PHARMACEUTICALS, INC. · R9AVS7XL2YB4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CMC PHARMACEUTICALS, INC. · R9AVS7XL2YB4
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- W911QY20C0003
- Award type code
- D
- Actions
- 4 · Oct 30, 2019 to Jul 9, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 9, 2021 | FY2021 | P00003 | A | $504,141.98 | — |
| Oct 26, 2020 | FY2021 | P00002 | G | $336,313.92 | — |
| Apr 1, 2020 | FY2020 | P00001 | M | $0.00 | — |
| Oct 30, 2019 | FY2020 | 0 | — | $626,226.72 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.